Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05487131 · ClinicalTrials.gov registry record · NA
Neuromodulation and Fatigue
A NA study of Fatigue and Healthy Aging, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05487131: Recruiting NA study of Fatigue and Healthy Aging, sponsored by University of Oklahoma.
NCT05487131 is a NA study of Fatigue and Healthy Aging that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 40 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05487131, a NA study of Fatigue and Healthy Aging, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
In this project, we aim to determine any potential effects of a weak electrical current applied to the neck or thoracic area on functional capacity and muscle activation. Healthy individuals will participate in one familiarization followed by three experimental sessions. Fatigability and motor function will be assessed in each test session.
Primary Outcome
Change in force will be evaluated with a device during each test session
Conditions Studied
Interventions
- BEHAVIORAL electrical stimulation
Study Locations (1)
Oklahoma
- University of Oklahoma - Norman
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-06-03 |
| Est. Completion | 2025-12-29 |
| Phase | NA |
What NCT05487131 shows while recruiting
NCT05487131 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Fatigue appearing as the primary indexed condition, and to 1 intervention - of which electrical stimulation is the first listed.
NCT05487131 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05487131 about?
NCT05487131 is a clinical study titled "Neuromodulation and Fatigue". In this project, we aim to determine any potential effects of a weak electrical current applied to the neck or thoracic area on functional capacity and muscle activation. Healthy individuals will participate in one familiarization followed by three experimental sessions. Fatigability and motor funct...
What is the current status of trial NCT05487131?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-06-03. Estimated completion is 2025-12-29.
What conditions does trial NCT05487131 study?
This clinical trial studies the following conditions: Fatigue, Healthy Aging.
What interventions are being tested in trial NCT05487131?
The interventions under investigation include: electrical stimulation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05487131?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05487131 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05487131's enrollment target sits among peer trials
40 71st of 109 higher than 35 of 109 other Fatigue trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI